Navigation Links
Regado Biosciences, Inc. Presents Results of the RADAR Phase 2b Clinical Trial of its REG1 Anticoagulation System
Date:4/3/2011

BASKING RIDGE, N.J., April 3, 2011 /PRNewswire/ -- Regado Biosciences, Inc., a privately held company pioneering the development of antithrombotic aptamers with active control agents, announced today the primary results of the RADAR Phase 2b clinical trial of the company's lead product, the anticoagulation system REG1, at the i2 Summit during the American College of Cardiology 2011 60th Annual Scientific Session & Expo in New Orleans, LA.  REG1 is a two-component system consisting of pegnivacogin, a highly selective Factor IXa (FIXa) inhibitor and anivamersen, its complementary specific active control agent.

The presentation, "A Randomized, Partially-Blinded, Multi-Center, Active-Controlled, Dose-ranging Study Assessing the Safety, Efficacy and Pharmacodynamics of the REG1 Anticoagulation System Compared to Unfractionated Heparin or Low Molecular Weight Heparin in Subjects with Acute Coronary Syndromes: Primary Results of the RADAR Randomized Clinical Trial," was made by Thomas J. Povsic, MD, PhD, Assistant Professor of Medicine at Duke University during an i2 Special Session titled "Interventional Featured Clinical Studies I."  

The international Phase 2b RADAR clinical trial was conducted in subjects admitted for ACS-unstable angina and myocardial infarction without ST-segment elevation (UA/NSTEMI) intended for cardiac catheterization within 24 hours.  The objectives of RADAR were to verify that 1 mg/kg of pegnivacogin resulted in near complete FIXa inhibition, to determine the dose of anivamersen which, when followed by immediate arterial sheath removal, results in a bleeding rate lower than heparin and to assess the efficacy of REG1 (based on ischemic event rates) as an anticoagulant system in an invasively managed ACS population.  The primary endpoint of the study was ACUITY bleeding (major and minor) at 30 days.  A secondary endpoint was
'/>"/>

SOURCE Regado Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Regado Biosciences to Present at the Needham & Companys 10th Annual Healthcare Conference in New York City
2. Regado Biosciences, Inc. Announces Presentation of the Results of the RADAR Phase 2b Clinical Trial of Its Anticoagulant System REG1 at the i2 Summit During the American College of Cardiology 2011 60th Annual Scientific Session & Expo in New Orleans
3. Regado Biosciences to Present at the 2011 RBC Capital Markets Healthcare Conference in New York City
4. Regado Biosciences, Inc. Introduces REG3, a Novel Aptamer-Based Inhibitor of Glycoprotein VI and its Matched Active Control Agent, at the American Heart Association (AHA) Scientific Sessions 2010 Meeting
5. Regado Biosciences, Inc. Presents Pharmacokinetic and Pharmacodynamic (PK/PD) Substudy Results From its Phase 2b RADAR Trial at the American Heart Association (AHA) Scientific Sessions 2010 Meeting
6. Regado Biosciences, Inc. Presents Two Abstracts on the Subcutaneous Depot Formulation of Pegnivacogin, a Nuclease-Stabilized RNA Aptamer, Direct Factor IXa Inhibitor and Part of the REG2 Anticoagulant System, at the American Heart Association (AHA)
7. Regado Biosciences to Present at the IMPACT 2010 Conference in Philadelphia, Pennsylvania
8. Regado Biosciences, Inc. Presents the First-In-Human Clinical Experience with REG2 at the American College of Chest Physicians (ACCP) Coagulation and Heart Disease Sessions in Vancouver, BC, Canada on November 2, 2010
9. Regado Biosciences to Present at the Stifel Nicolaus Healthcare Conference 2010 on September 16, 2010 in Boston, Massachusetts
10. Regado Biosciences to Present at the 2010 Wells Fargo Healthcare Conference on June 24, 2010 in Boston, Massachusetts
11. Regado Biosciences, Inc. Introduces REG2, Its Second Product Candidate, at the American College of Cardiology Conference, 59th Annual Scientific Session, in Atlanta, Georgia on March 15, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Ariz. , July 31 2014  Northsight Capital, ... has been named Chairman and CEO of the ... risk management, legal matters, business development and investment banking. ... the securities industry.  Before his career on Wall Street, ... Division of the U.S, Securities and Exchange Commission in ...
(Date:7/31/2014)...  Columbia Laboratories, Inc. (Nasdaq: CBRX ... results for the three and six-month periods ended ... results benefited from the contribution of the Molecular ... partially offset an anticipated and temporary decline in ... license renewal in one high-volume, high-margin market. Throughout ...
(Date:7/31/2014)... 31, 2014  Today,s Consumer Reports story on ... important reminder for consumers of the importance of ... initiatives such as the Acetaminophen Awareness Coalition,s (AAC) ... education campaign. Formed in 2010, the Coalition is ... consumer organizations dedicated to educating consumers on safe ...
Breaking Medicine Technology:Northsight Capital, Inc. Names Wall Street Veteran John Bluher, Former EVP And General Counsel Of Knight Trading Group, Chairman And CEO. 2Columbia Laboratories Reports Second Quarter 2014 Financial Results 2Columbia Laboratories Reports Second Quarter 2014 Financial Results 3Columbia Laboratories Reports Second Quarter 2014 Financial Results 4Columbia Laboratories Reports Second Quarter 2014 Financial Results 5Columbia Laboratories Reports Second Quarter 2014 Financial Results 6Columbia Laboratories Reports Second Quarter 2014 Financial Results 7Columbia Laboratories Reports Second Quarter 2014 Financial Results 8Columbia Laboratories Reports Second Quarter 2014 Financial Results 9Columbia Laboratories Reports Second Quarter 2014 Financial Results 10Columbia Laboratories Reports Second Quarter 2014 Financial Results 11Columbia Laboratories Reports Second Quarter 2014 Financial Results 12U.S. Health Coalition Calls for Continued Education on Acetaminophen, America's Most Common Drug Ingredient 2
... Nov. 17, 2011 Reportlinker.com announces that ... in its catalogue: Asia-Pacific ... http://www.reportlinker.com/p0336611/Asia-Pacific-Diagnostic-Imaging-Market-Outlook-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=NoCategory ... Summary ...
... Biotherapeutics (OTC.BB: NWBO) (Northwest Bio) today announced $2.4 million ... as an agreement to purchase the first $3 million ... agreement for an equity facility of up to $25 ... http://photos.prnewswire.com/prnh/20110329/SF73084LOGO ) The $2.4 million ...
Cached Medicine Technology:Asia-Pacific Diagnostic Imaging Market Outlook to 2017 2Asia-Pacific Diagnostic Imaging Market Outlook to 2017 3Asia-Pacific Diagnostic Imaging Market Outlook to 2017 4Asia-Pacific Diagnostic Imaging Market Outlook to 2017 5Asia-Pacific Diagnostic Imaging Market Outlook to 2017 6Asia-Pacific Diagnostic Imaging Market Outlook to 2017 7Asia-Pacific Diagnostic Imaging Market Outlook to 2017 8Asia-Pacific Diagnostic Imaging Market Outlook to 2017 9Asia-Pacific Diagnostic Imaging Market Outlook to 2017 10Asia-Pacific Diagnostic Imaging Market Outlook to 2017 11Asia-Pacific Diagnostic Imaging Market Outlook to 2017 12Asia-Pacific Diagnostic Imaging Market Outlook to 2017 13Asia-Pacific Diagnostic Imaging Market Outlook to 2017 14Asia-Pacific Diagnostic Imaging Market Outlook to 2017 15Asia-Pacific Diagnostic Imaging Market Outlook to 2017 16Asia-Pacific Diagnostic Imaging Market Outlook to 2017 17Asia-Pacific Diagnostic Imaging Market Outlook to 2017 18Asia-Pacific Diagnostic Imaging Market Outlook to 2017 19Northwest Bio Announces Transactions for $5.4 Million in New Financing 2Northwest Bio Announces Transactions for $5.4 Million in New Financing 3
(Date:7/31/2014)... FRANCISCO & ATLANTA (PRWEB) July 31, 2014 ... executive networking and relationship-marketing firm, honored finalists and ... ISE® West Executive Forum and Awards Gala at ... , Max Solonski, director of information security for ... Security Executive® of the Year Award winner for ...
(Date:7/31/2014)... Steven Reinberg HealthDay Reporter ... Strict regulation of electronic cigarettes isn,t warranted based on ... the contrary, allowing e-cigarettes to compete with regular cigarettes ... after reviewing 81 prior studies on the use and ... evidence suggests that there is a potential for smokers ...
(Date:7/31/2014)... 31, 2014 Ethane Web Technologies, ... introduced a new service named ‘Java Development’. The ... Technologies has designed the service after doing a ... Java Development service being provided by other web ... confidence to promise outstanding Java Development service. ...
(Date:7/31/2014)... Bedros Keuilian’s Fit Body Boot Camp franchise ... countries. At his annual Fitness Business Summits, some of the ... marketing strategies. But in his latest blog post, he shares ... a personal training business is to create free fitness ... trainer has a certain area that they really feel strongly ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Dallas Fit ... Street, Dallas, Texas to 3821 Ross Avenue, also in Dallas, ... current and potential members to burn fat and get in ... this move because he believes that the new space will ... and fitness results they want as well as accommodate new ...
Breaking Medicine News(10 mins):Health News:Max Solonski, Caesars Entertainment Claim Top Awards at ISE® West Ralph Johnson (King County, WA) named People’s Choice Award Winner 2Health News:Max Solonski, Caesars Entertainment Claim Top Awards at ISE® West Ralph Johnson (King County, WA) named People’s Choice Award Winner 3Health News:Max Solonski, Caesars Entertainment Claim Top Awards at ISE® West Ralph Johnson (King County, WA) named People’s Choice Award Winner 4Health News:Benefits of E-Cigarettes May Outweigh Harms, Study Finds 2Health News:Benefits of E-Cigarettes May Outweigh Harms, Study Finds 3Health News:Ethane Web Technologies Announces Java Development Service at Pocket Friendly Cost 2Health News:Bedros Keuilian’s New Post Explains the Value of Fitness Information Products in Marketing a Personal Training Business 2Health News:Bedros Keuilian’s New Post Explains the Value of Fitness Information Products in Marketing a Personal Training Business 3Health News:Dallas Fit Body Boot Camp Moves to New Location, Announces Grand Opening Set for Saturday August 9th 2
... been treated by removing a disc or placing a bone ... an artificial disc which is being studied as a replacement ... study that was recently completed compared the prosthesis to traditional ... randomized, with one having a fusion operation for every two ...
... Pace University in New York found from an analysis of ... found that the percentage of women who quit smoking rose ... of those were unable to remain ex-smokers six months after ... of Preventive Medicine suggested that the results varied among groups. ...
... related injuries to the back, in children. However, researchers in ... injuries to the heads and faces of children than they ... the January issue of Pediatrics. ,The study covered all ... to the National Electronic Injury Surveillance System of the U.S. ...
... many including genetic abnormalities. Earlier studies have shown that ... failure and this discovery is now being used as ... against heart failure. ,The research which was carried ... that delivering a gene that helps the heart to ...
... that are treated with angioplasty or a transplantation may ... there is an ever-present risk of rejection of the// ... causes damage to the vessel walls. This in turn ... however, revealed that pre-treatment with carbon monoxide may protect ...
... most common diseases among children that were known until ... recently, researchers and neurologists have found that stroke is ... newborns that often go unnoticed. A National Hospital's database ... the University of California showed that four in 1000 ...
Cached Medicine News:Health News:Artificial discs available as replacements for damaged discs 2Health News:Stroke also in list of common childhood ailments 2
... The AlphaPette Pipettor is the #1 ... Offers accuracy, comfort, and reliability. Continuously ... volume readout sub-micrometer. Easy interchangeable ejector ... tiny hands. Adjustable rapid pipet tip ...
... Thermo Labsystems was designed specifically to combine ... such as the new fast dial system ... help to define this as a new ... interchangeable handle plate offers a custom fit ...
... Reference Series 2000 Pipette is a synonym ... compact and robust design, and superior operating ... to operate the measuring stroke and blow-out ... Product features: Eppendorf "pipette/tip" system ensures ...
... The Integrity family of pacemakers ... and truly automatic devices in today's ... combination of automated features and diagnostic ... popular and proven Affinity pacemakers platform. ...
Medicine Products: